Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine or Haloperidol in First Episode Schizophrenia

NCT00169091 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.

NCT NCT00169091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine or Haloperidol in First Episode Schizophrenia
Lead sponsor
Harvard Medical School (HMS and HSDM)
Phase
Phase 4
Overall status
Terminated
Start date
March 31, 1996
Completion date
October 31, 2003
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia